Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies

Mostrar otras versiones (1)

BACKGROUND: Serology tests can identify previous infections and facilitate estimation of the number of total infections. However, immunoglobulins targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported to wane below the detectable level of serological assays. We est...

Descripción completa

Detalles Bibliográficos
Autores principales: Shioda, Kayoko, Lau, Max SY, Kraay, Alicia NM, Nelson, Kristin N, Siegler, Aaron J, Sullivan, Patrick S, Collins, Matthew H, Weitz, Joshua S, Lopman, Benjamin A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685353/
https://www.ncbi.nlm.nih.gov/pubmed/33236035
http://dx.doi.org/10.1101/2020.11.13.20231266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685353/
https://www.ncbi.nlm.nih.gov/pubmed/33236035
http://dx.doi.org/10.1101/2020.11.13.20231266

Ejemplares similares